We’re addressing two closely related but underserved markets: advanced upper-limb prosthetics and dexterous end effectors for humanoid robots. In prosthetics, the problem is access. Most bionic hands are either too expensive, too fragile, or too limited in functionality. In robotics, the challenge is time and cost. Humanoid companies need hands, but building them in-house is resource-heavy and slows time to market. We solve both by offering a modular, repairable, and affordable bionic hand platform that serves both markets without compromise.